OR WAIT null SECS
June 07, 2018
The company will provide the first FlexFactory manufacturing platform for cell therapy manufacturing.
June 01, 2018
TxCell announces manufacturing agreement with Lonza for its HLA-A2 CAR-Treg cellular product.
May 16, 2018
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 15, 2018
Naturally occurring and engineered albumins are being explored as a tool to enhance the stability of drugs, including biologics, and extend shelf-life.
May 10, 2018
The companies have extended a contract agreement for the commercial manufacture of the active pharmaceutical ingredient for vonapanitase, an investigational drug intended to improve hemodialysis vascular access outcomes.
April 20, 2018
The new platform is expected to speed up cell line development.
April 16, 2018
Kemiex trading network is designed to increase safety in the sourcing of APIs and additives.
April 10, 2018
The new 300,000-square-foot facility is considered the largest dedicated cell and gene therapy manufacturing facility with fully integrated services.
April 05, 2018
The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.
April 02, 2018
CMOs/CDMOs that are easy to work with, have demonstrated performance track records, and plan for the future are preferred.